Lifetime Data Analysis

, Volume 9, Issue 2, pp 175–193 | Cite as

Survivor Function Estimators Under Group Sequential Monitoring Based on the Logrank Statistic

  • Malka Gorfine
Article
  • 58 Downloads

Abstract

In this paper we investigate a group sequential analysis of censored survival data with staggered entry, in which the trial is monitored using the logrank test while comparisons of treatment and control Kaplan-Meier curves at various time points are performed at the end of the trial. We concentrate on two-sample tests under local alternatives. We describe the relationship of the asymptotic bias of Kaplan-Meier curves between the two groups. We show that even if the asymptotic bias of the Kaplan-Meier curve is negligible relative to the true survival, this is not the case for the difference between the curves of the two arms of the trial. A corrected estimator for the difference between the survival curves is presented and by simulations we show that the corrected estimator reduced the bias dramatically and has a smaller variance. The methods of estimation are applied to the Beta-Blocker Heart Attack Trial (1982), a well-known group sequential trial.

group sequential test secondary parameter Kaplan-Meier curve logrank test local alternatives 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. P. K. Andersen, O. Borgan, R. D. Gill, and N. Keiding, Statistical Models Based on Counting Processes, Springer-Verlag: New-York, 1993.Google Scholar
  2. P. Armitage, Sequential Medical Trials, first and second edition, Blackwell: Oxford, UK, 1960, 1975.Google Scholar
  3. Beta-Blocker Heart Attack Trial Research Group, “A randomized trial on propranolol in patients with acute myocardial infarction,” The Journal of the American Medical Association vol. 247 pp. 1707–1714, 1982.Google Scholar
  4. D. L. DeMets, R. Hardy, L. M. Friedman, and K. K. G. Lan, “Statistical aspects of early termination in the beta-blocker heart attack trial,” Controlled Clinical Trials vol. 5 pp. 362–372, 1984.Google Scholar
  5. S. S. Emerson and P. L. C. Banks, “Estimation of secondary outcomes following a group sequential trial,” Presentation at ENAR Biometric Society Conference, Cincinnati, OH, May 1992.Google Scholar
  6. S. S. Emerson and T. R. Fleming, “Parameter estimation following a group sequential hypothesis testing,” Biometrika vol. 77 pp. 875–892, 1990.Google Scholar
  7. K. M. Facy and J. Whitehead, “An improved approximation for calculation of confidence intervals after a sequential clinical trial,” Statistics in Medicine vol. 9 pp. 1277–1285, 1990.Google Scholar
  8. M. Gorfine, “Estimation of a secondary parameter in a group sequential clinical trial,” PhD Thesis, The Hebrew University of Jerusalem, Israel, 1999.Google Scholar
  9. M. Gorfine, “Estimation of a secondary parameter in a group sequential clinical trial,” Biometrics vol. 57 pp. 589–597, 2001.Google Scholar
  10. C. Jennison, “Sequential methods for medical experiments,” PhD Thesis, Cornell University, 1982.Google Scholar
  11. C. Jennison and B. W. Turnbull, “Confidence interval for a binomial parameter following a multistage test with application to MIL-STD 105D and medical trials,” Technometrics vol. 25 pp. 49–58, 1983.Google Scholar
  12. C. Jennison and B. W. Turnbull, “Repeated confidence intervals for group sequential clinical trials,” Control Clinical Trials vol. 5 pp. 33–45, 1984.Google Scholar
  13. C. Jennison and B. W. Turnbull, “Repeated confidence intervals for the median survival time,” Biometrika vol. 72 pp. 619–625, 1985.Google Scholar
  14. C. Jennison and B. W. Turnbull, Group Sequential Methods with Applications to Clinical Trials, Chapman and Hall/CRC: Boca Raton and London, 2000.Google Scholar
  15. M. G. Gu and T. L. Lai, “Weak convergence of time-sequential censored rank statistics with application to sequential testing in clinical trials,” Annals of Statistics vol. 19 pp. 1403–1433, 1991.Google Scholar
  16. J. D. Kalbfleisch and R. L. Prentice, The Statistical Analysis of Failure Time Data, Wiley: New York, 1980.Google Scholar
  17. E. L. Kaplan and P. Meier, “Non-parametric estimation from incomplete observations,” Journal of the American Statistical Association vol. 53 pp. 457–481, 562-563, 1958.Google Scholar
  18. D. Siegmund, “Estimation following sequential tests,” Biometrika vol. 65 pp. 341–349, 1978.Google Scholar
  19. N. Starr and M. Woodroofe, “Remark on a stopping time,” Proc. Nat. Acad. Ser. vol. 61 pp. 1215–1218, 1968.Google Scholar
  20. A. A. Tsiatis, G. L. Rosner, and R. C. Mehta, “Exact confidence intervals following a group sequential test,” Biometrics vol. 40 pp. 797–803, 1984.Google Scholar
  21. J. Whitehead, The Design and Analysis of Sequential Clinical Trials, Ellis Horwood: Chichester, England, 1983.Google Scholar
  22. J. Whitehead, “On the bias of maximum likelihood estimation following a sequential test,” Biometrika vol. 73 pp. 573–581, 1986a.Google Scholar
  23. J. Whitehead, “Supplementary analysis at the conclusion of a sequential clinical trial,” Biometrics vol. 42 pp. 461–471, 1986b.Google Scholar
  24. M. Woodroofe, “Estimation after sequential testing: A simple approach for truncated sequential probability ratio test,” Biometrika vol. 79 pp. 347–353, 1992.Google Scholar
  25. B. Yakir, “Secondary inference in a sequential clinical trial,” A technical report, 1994.Google Scholar
  26. B. Yakir, “On the distribution of a concomitant statistic in a sequential trial,” Sequential Analysis vol. 16 pp. 287–294, 1997.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Malka Gorfine
    • 1
  1. 1.Fred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations